comparemela.com

Page 5 - Maury Raycroft News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CRISPR eyes autoimmune disease in revamp of cell therapy plans

Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Q4 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today s recorded presentation, all participants will be in a listen-only.

vimarsana © 2020. All Rights Reserved.